Isoproterenol vs Dopamine in Bradycardia Treatment Outcomes

This presentation evaluates the comparative effectiveness of isoproterenol and dopamine in managing bradycardia, addressing the lack of standardized protocols. Through a retrospective chart review (2023-2024), 100 cases were analyzed, finding comparable effectiveness with faster but less cost-efficient outcomes for isoproterenol. Dopamine is highlighted for cost-effectiveness and practical use in resource allocation. Limitations include a small sample size and dosing inconsistencies....